Life Technologies Leads Latin American Next-Generation Sequencing: Kalorama Report

Share Article

A majority of the next-generation sequencing systems installed in Latin America are of the Life Technologies brand, according to “Next-Generation Sequencing in Latin America", a recent report by Kalorama Information. The Carlsbad, CA-based company leads its rivals Roche and Illumina in this region.

A majority of the next-generation sequencing systems installed in Latin America are of the Life Technologies brand, according to a recent report by Kalorama Information with VA Consultora y Asociados. Kalorama and VA Consultora y Asociados say that the Carlsbad, CA-based company leads its rivals Roche and Illumina in this region. The finding was made in the report, “Next-Generation Sequencing in Latin America”.

The report found most systems were in Brazil and Mexico, though next-generation sequencing is also present in Argentina, Columbia, Peru and other countries. In terms of number of systems, Life Technologies with 65% units installed is leading the regional market, followed by Illumina, Roche and others.    According to Kalorama this is a much higher installed base than exists in the United States.

“Life Technologies systems benefit from a well established distribution network and legacy installed base,” said Bruce Carlson, Publisher of Kalorama Information. “We expect that over the years as NGS grows in this region, the rivals will catch up.”

The report says that Life Technologies has subsidiaries in Argentina, Brazil, Chile and Mexico plus a huge distributor’s network segmented by product line (Human Identification, HLA, ABI products, Invitrogen products, etc.), while Illumina have recently opened a subsidiary in Brazil and was the last player to start operations with their own sales and support force in Latin American market. As science and technology spending expands, next-generation systems are expected to show an increase.

“Most of the Latin Amercian countries but especially Brazil, Mexico, Argentina, Chile and Uruguay show a constant and sustained increase of its investment in S&T as a percentage of GDP. It is consistent with the investment trend and goals defined by governmental and private sectors,” the report said.

Kalorama’s market survey “Next-Generation Sequencing in Latin America” and analysis shows information about geographical distribution, lab category distribution, manufacturer’s analysis, instruments distribution by throughput category and market trends for the coming years. http://www.kaloramainformation.com/Generation-Sequencing-Latin-8014935/

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bruce Carlson
Follow us on
Visit website